These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24613320)

  • 1. Put off till tomorrow what you can do today.
    Antoniucci D
    J Am Coll Cardiol; 2014 May; 63(20):2099-2100. PubMed ID: 24613320
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI).
    Carrick D; Oldroyd KG; McEntegart M; Haig C; Petrie MC; Eteiba H; Hood S; Owens C; Watkins S; Layland J; Lindsay M; Peat E; Rae A; Behan M; Sood A; Hillis WS; Mordi I; Mahrous A; Ahmed N; Wilson R; Lasalle L; Généreux P; Ford I; Berry C
    J Am Coll Cardiol; 2014 May; 63(20):2088-2098. PubMed ID: 24583294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between neutrophil counts on admission and angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Wang Z; Ren L; Lei L; Ye H; Peng J
    Acta Cardiol; 2016 Apr; 71(2):241-6. PubMed ID: 27090048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The no-reflow phenomenon: State of the art.
    Bouleti C; Mewton N; Germain S
    Arch Cardiovasc Dis; 2015 Dec; 108(12):661-74. PubMed ID: 26616729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive performance of dual modality of computed tomography angiography and intravascular ultrasound for no-reflow phenomenon after percutaneous coronary stenting in stable coronary artery disease.
    Okutsu M; Horio T; Tanaka H; Akiyama M; Okimoto N; Tsubouchi T; Kawajiri K; Ohashi Y; Sumitsuji S; Ikari Y
    Heart Vessels; 2018 Oct; 33(10):1121-1128. PubMed ID: 29644449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Platelet-leukocyte Aggregates Are Associated With Myocardial No-reflow in Patients With ST Elevation Myocardial Infarction.
    Ren F; Mu N; Zhang X; Tan J; Li L; Zhang C; Dong M
    Am J Med Sci; 2016 Sep; 352(3):261-6. PubMed ID: 27650230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil reverses myocardial no-reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Fu Q; Lu W; Huang YJ; Wu Q; Wang LG; Wang HB; Jiang SZ; Wang YJ
    Cell Biochem Biophys; 2013; 67(3):911-4. PubMed ID: 23559273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of initial and residual thrombus burden on the no-reflow phenomenon in patients with ST-segment elevation myocardial infarction.
    Ahn SG; Choi HH; Lee JH; Lee JW; Youn YJ; Yoo SY; Cho BR; Lee SH; Yoon J
    Coron Artery Dis; 2015 May; 26(3):245-53. PubMed ID: 25503419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of clopidogrel resistance on ST-segment resolution and no-reflow in acute myocardial infarction with ST-elevation patients treated with a primary percutaneous coronary intervention.
    Bozbeyoglu E; Satilmis S; Aksu H; Yildirimturk O; Nurkalem Z
    Coron Artery Dis; 2012 Dec; 23(8):523-7. PubMed ID: 23011413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
    Kurtul A; Yarlioglues M; Murat SN; Ergun G; Duran M; Kasapkara HA; Demircelik MB; Cetin M; Ocek AH
    Am J Cardiol; 2014 Aug; 114(3):342-7. PubMed ID: 24948493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of the SYNTAX score to predict "no reflow" in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Magro M; Nauta ST; Simsek C; Boersma E; van der Heide E; Regar E; van Domburg RT; Zijlstra F; Serruys PW; van Geuns RJ
    Am J Cardiol; 2012 Mar; 109(5):601-6. PubMed ID: 22177003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of serum procalcitonin level with the no-reflow phenomenon after a primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
    Murat SN; Kurtul A; Celik IE; Duran M; Yarlioglues M; Kilic A; Elcik D
    Coron Artery Dis; 2016 Mar; 27(2):116-21. PubMed ID: 26709984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of no-reflow in culprit lesion versus culprit vessel PCI in acute STEMI.
    Arslan U; Yaman M; Kocaoğlu İ; Turan OE; Yücel H; Aksakal A; Günaydin İA; Hakan Ateş A
    Coron Artery Dis; 2015 Sep; 26(6):510-5. PubMed ID: 26086864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction.
    Harrison RW; Aggarwal A; Ou FS; Klein LW; Rumsfeld JS; Roe MT; Wang TY;
    Am J Cardiol; 2013 Jan; 111(2):178-84. PubMed ID: 23111142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of lymphocyte-to-monocyte ratio with the no-reflow phenomenon in patients who underwent a primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Kurtul A; Yarlioglues M; Celik IE; Duran M; Elcik D; Kilic A; Oksuz F; Murat SN
    Coron Artery Dis; 2015 Dec; 26(8):706-12. PubMed ID: 26340546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Effects of Intracoronary Tirofiban on No-Reflow Phenomena in Patients With ST-Segment Elevated Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Akpek M; Sahin O; Sarli B; Baktir AO; Saglam H; Urkmez S; Ergin A; Oguzhan A; Arinc H; Kaya MG
    Angiology; 2015 Jul; 66(6):560-7. PubMed ID: 25092681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of NT-proBNP on admission for early risk stratification of patients undergoing primary percutaneous coronary intervention.
    Ayhan E; Isık T; Uyarel H; Ergelen M; Cicek G; Ozyurtlu F; Ghannadian B; Tanboga IH
    Kardiol Pol; 2013; 71(2):165-75. PubMed ID: 23575711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of intraplatelet melatonin levels to predict angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Jimenez-Sosa A; Avanzas P; Bosa-Ojeda F; Kaski JC
    Am J Cardiol; 2010 Dec; 106(11):1540-4. PubMed ID: 21094352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Closed versus open cell stent for high-risk percutaneous coronary interventions in ST-elevation acute myocardial infarction: the Closed versus Open Cells stent for High risk percutaneous coronary Interventions in ST-Elevation acute myocardial infarction (COCHISE) pilot study.
    Sciahbasi A; Pendenza G; Golino L; Romagnoli E; Caferri G; Patrizi R; Summaria F; Serra F; Giannico MB; Bruno E; Sommariva L; Lioy E
    Am Heart J; 2013 Mar; 165(3):415-20. PubMed ID: 23453112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative stents in ST-segment elevation myocardial infarction: improving the efficacy of primary percutaneous coronary intervention.
    Yetgin T; Nakatani S; Onuma Y; van Geuns RJ
    Future Cardiol; 2015 May; 11(3):347-57. PubMed ID: 26021640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.